Gelesis is a clinical stage company developing a new category of therapy to safely treat overweight, obese and diabetic patients. The Gelesis executive and advisory team includes the world's top experts in obesity research and clinical development, former regulatory leaders, entrepreneurs and innovators in advanced materials. Gelesis was co-founded by PureTech, a venture creation company tackling tomorrow's biggest healthcare problems.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/19/14 | $12,000,000 |
Pritzker/Vlock Family Office | undisclosed | |
| 03/30/15 | undisclosed | |||
| 12/19/15 | $31,500,000 | Growth |
Cormorant Asset Management INVESCO Private Capital Pritzker/Vlock Family Office | undisclosed |
| 12/09/19 | $84,600,000 |
Vitruvian Partners | undisclosed |
